City of Hope's Ravi Salgia Discovers New Biomarker Link in Nonsmall Cell Lung Cancer
December 7, 2017 | Elise Lamar
Ravi Salgia, M.D., Ph.D., recently published in Scientific Reports about a novel and promising link between two NSCLC biomarkers. The study might help oncologists match patients with effective drug interventions against specific forms of NSCLC.
Advanced Lung Cancer Patient: ‘I’m Not About to Go Quietly into the Night’
November 30, 2017 | Julia F.
Julie F., 59, of Wisconsin, survived advanced small cell lung cancer after 29 rounds of chemotherapy, five weeks of radiation and experimental immunotherapy. This is her story.
City of Hope’s Ravi Salgia, M.D., Ph.D., honored for outstanding contributions to oncology
June 2, 2017 | Letisia Marquez
City of Hope’s Ravi Salgia, M.D., Ph.D., whose accomplishments as a medical oncologist and researcher have helped shape modern cancer medicine, was celebrated at ASCO by the Indo-American Cancer Association (IACA) for his contributions to the field.
City of Hope's Ravi Salgia, M.D., receives award for treatment, research on lung cancer
November 16, 2016 | Letisia Marquez
City of Hope’s Ravi Salgia, M.D., Ph.D., chair of the Department of Medical Oncology and Therapeutics Research, has received yet another accolade that recognizes his decades-long dedication to treating lung cancer patients and researching new therapies.